Tussicaps

Catarrh, Migraine, Coughing + 55 more

Treatment

6 FDA approvals

20 Active Studies for Tussicaps

What is Tussicaps

Chlorpheniramine

The Generic name of this drug

Treatment Summary

Hydrocodone is a powerful painkiller that is usually taken in combination with acetaminophen to treat moderate to severe pain. It used to be used as a cough suppressant but has since been replaced by dextromethorphan in cough and cold medicines. Hydrocodone’s more potent metabolite, hydromorphone, is sometimes prescribed for severe pain. Hydrocodone was first approved for use by the FDA in 1943 as part of the cough suppressant syrup Hycodan.

Rynatuss

is the brand name

Tussicaps Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Rynatuss

Chlorpheniramine

1960

47

Approved as Treatment by the FDA

Chlorpheniramine, also known as Rynatuss, is approved by the FDA for 6 uses including Acute Bronchitis and Cold .

Acute Bronchitis

Used to treat Cough in combination with Hydrocodone

Cold

Used to treat Cold in combination with Hydrocodone

Allergic Rhinitis (AR)

Allergy to Tree Pollen

upper respiratory symptoms

Used to treat upper respiratory symptoms in combination with Hydrocodone

Hypersensitivity

Used to treat Allergic Reaction in combination with Hydrocodone

Effectiveness

How Tussicaps Affects Patients

Hydrocodone is a painkiller that works by blocking pain signals from reaching the brain. It also produces feelings of euphoria, slowed breathing, and drowsiness.

How Tussicaps works in the body

Hydrocodone works by targeting two kinds of opioid receptors in the body: mu and delta. It binds to these receptors, stopping nerve signals that would normally lead to pain. It also affects the brain's reward system, producing a feeling of pleasure. Hydrocodone also has an inhibitory effect on GABAergic neurons in the ventral tegmental area, leading to sedation and respiratory depression. The effects of delta opioid receptors are not as well studied but may also contribute to pain relief.

When to interrupt dosage

The recommended measure of Tussicaps is contingent upon the determined illness, including Coughing, Coughing and Chronic Pain. The exact amount of dosage is dependent upon the method of administration (e.g. Tablet, extended release - Oral or Tablet - Oral) featured in the table below.

Condition

Dosage

Administration

Sinusitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

IgA Vasculitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Migraine

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Asthma

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Drug Allergy

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Sneezing

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Asthma

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Hives

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Pink Eye

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Conjunctivitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Allergy to Tree Pollen

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Inflammation

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Angioedema

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Coughing

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Dermatitis, Allergic Contact

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Coughing

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Airway secretion clearance therapy

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Itching of the throat

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Nose

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Acute Bronchitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Capsule, liquid filled - Oral, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Powder, for solution - Oral, Capsule, liquid filled, Capsule, Tablet, extended release, Tablet, extended release - Oral, Capsule - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder - Oral, Powder, for solution, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Lozenge, Lozenge - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, multilayer, Tablet, multilayer - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder, Kit; Powder - Oral, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Kit - Oral, Topical, Liquid - Topical, Solution / drops, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Warnings

Tussicaps has twenty-one restrictions. It should not be taken in combination with any of the circumstances detailed in the following table.

There are 20 known major drug interactions with Tussicaps.

Common Tussicaps Drug Interactions

Drug Name

Risk Level

Description

Amoxapine

Major

The metabolism of Amoxapine can be decreased when combined with Chlorpheniramine.

Anagrelide

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Anagrelide.

Arsenic trioxide

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Arsenic trioxide.

Artemether

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Artemether.

Asenapine

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Asenapine.

Tussicaps Toxicity & Overdose Risk

Taking too much hydrocodone can lead to serious symptoms such as breathing problems, sleepiness, lack of muscle movement, cold and clammy skin, small pupils, fluid in the lungs, slow heartbeat, low blood pressure, or even death. To respond to an overdose, a person must be given oxygen and possibly assisted ventilation. Other treatments may include IV fluids, oxygen, and medication to raise blood pressure. Emergency medical help should be called if the person experiences cardiac arrest or an irregular heartbeat. A medication called naloxone can be administered to reverse the effects of the overdose, but medical attention is still necessary as the effects of

image of a doctor in a lab doing drug, clinical research

Tussicaps Novel Uses: Which Conditions Have a Clinical Trial Featuring Tussicaps?

50 active clinical trials are currently being conducted to investigate the potential of Tussicaps to alleviate Chronic Pain, Nasal Congestion stemming from the Common Cold and Acute Bronchitis.

Condition

Clinical Trials

Trial Phases

Asthma

97 Actively Recruiting

Phase 1, Phase 4, Not Applicable, Early Phase 1, Phase 2, Phase 3

Migraine

52 Actively Recruiting

Phase 4, Phase 1, Not Applicable, Phase 3, Phase 2, Early Phase 1

Transfusion Reaction

0 Actively Recruiting

Pink Eye

0 Actively Recruiting

Nasal Congestion

0 Actively Recruiting

Hypersensitivity

1 Actively Recruiting

Phase 4

Headache

0 Actively Recruiting

ocular hyperemia

0 Actively Recruiting

Influenza

0 Actively Recruiting

Conjunctivitis

0 Actively Recruiting

Coughing

0 Actively Recruiting

Airway secretion clearance therapy

0 Actively Recruiting

Nose

0 Actively Recruiting

Allergy to vaccine

0 Actively Recruiting

Angioedema

0 Actively Recruiting

Rhinorrhea

0 Actively Recruiting

Seasonal Allergic Conjunctivitis

0 Actively Recruiting

Cold

0 Actively Recruiting

Lacrimal Apparatus Diseases

0 Actively Recruiting

Coughing

0 Actively Recruiting

Tussicaps Reviews: What are patients saying about Tussicaps?

5

Patient Review

12/27/2009

Tussicaps for Cough

I really liked this cough suppressant! I was hesitant to try a pill, but it worked great. No nasty taste or mess like with syrup, and it made me feel relaxed and happy without being too drowsy.

5

Patient Review

12/15/2009

Tussicaps for Cough

I was worried that, at $4 a pill, these wouldn't work. But I was amazed--they were awesome. After a month of suffering with a sinus and upper respiratory infection that wouldn't go away, this stopped the cough the others couldn't. My chest felt like i had been beaten up until i took them. All I can say is wow and thank you!

5

Patient Review

12/4/2009

Tussicaps for Cough

I would not recommend this medication to anyone. I had a terrible experience with it and suffered through restless nights, vomiting, dizziness, and headaches.

5

Patient Review

1/20/2010

Tussicaps for Cough

I was in a lot of pain from coughing for four days straight before I tried this treatment. Within just a few hours, the cough began to subside and within six hours it had almost completely stopped. And on top of that, the pain was gone too!

5

Patient Review

12/14/2010

Tussicaps for Cough

This is an effective treatment, and worth the price tag.

5

Patient Review

3/20/2010

Tussicaps for Cough

Though this treatment effectively got rid of my cough, the side effects were not worth it. I felt nauseous and dizzy for an entire day after just one dose.

5

Patient Review

1/13/2015

Tussicaps for Cough

Tussicaps, used in conjunction with an antibiotic, cleared up my respiratory infection and cough very effectively. I'm now able to go back to work without any issues.

5

Patient Review

10/29/2009

Tussicaps for Cough

5

Patient Review

4/28/2012

Tussicaps for Cold Symptoms

I had a severe reaction to this medication a few hours after taking only one capsule. I was administered Benedryl (maximum dose) three times during the day, and I'm still having some reactions 24 hours later, although they are not as severe. I contacted the company to determine which ingredient most likely caused this effect so that I can avoid it in the future. This has been very scary for me, with large welts that look almost like blisters, and are very red and itchy.

4.7

Patient Review

12/18/2009

Tussicaps for Cough

This medicine was very effective at suppressing my cough and stopping the burning pain in my chest. The drowsiness it caused was a bit of an issue, but since I was already out of work sick, it wasn't really a problem for me.

4.3

Patient Review

11/6/2009

Tussicaps for Cough

While this treatment didn't stop my coughing at all, it did help me get through the bronchitis a bit easier.

3.7

Patient Review

5/7/2011

Tussicaps for Cold Symptoms

Tussicaps are a great option for those with an upper respiratory issue. They work quickly and last for several hours. The only downside is that they can cause lightheadedness if taken on an empty stomach, but it's a small price to pay for the relief they provide.

3

Patient Review

1/6/2010

Tussicaps for Cough

I was never aware of this medication until my doctor prescribed it for me. It's been really helpful in reducing my cough reflex.

2.3

Patient Review

10/7/2009

Tussicaps for Cough

2.3

Patient Review

10/28/2009

Tussicaps for Cough

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about tussicaps

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the drug tussionex?

"TUSSIONEX Pennkinetic Extended-Release Suspension is a prescription medicine used to treat cough and upper respiratory symptoms that you can have with allergies or a cold. TUSSIONEX Pennkinetic Extended-Release Suspension is for adults and children aged 6 years and older."

Answered by AI

What is Deconamine used for?

"Decongestants help to reduce swelling in the nasal passages.

This medication is a combination of an antihistamine and a decongestant and is used to relieve symptoms of the common cold, flu, allergies, or other breathing illnesses temporarily. Antihistamines help relieve watery eyes, itchy eyes/nose/throat, runny nose, and sneezing while decongestants help reduce swelling in the nasal passages."

Answered by AI

What are TussiCaps used for?

"- The FDA has approved TussiCaps (acetaminophen, dextromethorphan, guaifenesin, and phenylephrine) oral suspension, the first fixed-dose combination of these four drugs in a single product.

TussiCaps has been approved by the FDA to treat runny nose, sneezing, itching, watery eyes, and cough caused by allergies, the common cold, or the flu. This is the first fixed-dose combination of these four drugs in a single product."

Answered by AI

Clinical Trials for Tussicaps

Image of Allergy and Clinical Immunology Associates in Pittsburgh, United States.

Tilrekimig for Asthma

12 - 80
All Sexes
Pittsburgh, PA

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. The study is seeking participants who: * Have a history of severe asthma for at least 12 months * Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given shots of study medicine or a placebo at the study clinic. Tilrekimig or the placebo will be given about every 4 weeks during the study. The study will compare the experiences of people receiving tilrekimig to those people who receive the placebo. This will help determine if tilrekimig is safe and effective.

Phase 3
Recruiting

Allergy and Clinical Immunology Associates (+2 Sites)

Pfizer CT.gov Call Center

Pfizer

Image of Ontario Tech University in Oshawa, Canada.

Temperature & Humidity Exposure for Asthma

11 - 18
All Sexes
Oshawa, Canada

The goal of this clinical study is to learn how different temperature and humidity conditions affect breathing, lung function, exercise capacity, symptoms, and other physical responses in children and youth aged 11 to 18 years with asthma, compared with age- and sex-matched children and youth without asthma. The main questions it aims to answer are: * How do different temperature and humidity conditions affect lung function, breathing symptoms, exercise capacity, and physiological responses in children and youth with asthma? * Do children and youth with asthma respond differently to these environmental conditions than children and youth without asthma? * Do sex and gender influence these responses? Researchers will compare children and youth with asthma to age- and sex-matched children and youth without asthma to see if temperature and humidity exposures have different effects on breathing, exercise performance, symptoms, and physiological responses. Participants will: * Attend two study visits in a climate-controlled chamber. * Be exposed to hot, cold, and varying humidity conditions for short periods of time. * Complete breathing tests and exercise testing before, during, and after each exposure. * Have symptoms, physical activity, and physiological responses monitored throughout the study.

Waitlist Available
Has No Placebo

Ontario Tech University

Image of UPMC Children's Community Pediatrics in Pittsburgh, United States.

Enhanced Telemedicine for Acute Respiratory Tract Infections

6 months - 24 months
All Sexes
Pittsburgh, PA

Young children often receive antibiotics for pediatric acute respiratory tract infections (ARTIs) - common childhood diagnoses like ear infections, strep throat, sinusitis, and colds - but many of these antibiotics are prescribed unnecessarily for viral infections, where antibiotics will not help. Helping families and pediatricians to evaluate children with ARTIs through primary care telemedicine visits using at-home tele-otoscopes vs. at-home eBooks could help reduce unnecessary antibiotic exposure in children. In this clinical trial, we will assess the impact of at-home tele-otoscope vs. eBook enabled primary care telemedicine on antibiotic use, healthcare utilization, and healthcare costs for young children.

Waitlist Available
New This Month

UPMC Children's Community Pediatrics (+1 Sites)

Kristin Ray, MD, MS

Have you considered Tussicaps clinical trials?

We made a collection of clinical trials featuring Tussicaps, we think they might fit your search criteria.
Go to Trials
Image of Emory University Hospital (EUH) in Atlanta, United States.

Influenza Transmission Study

18 - 49
All Sexes
Atlanta, GA

The purpose of this study is to determine whether influenza A or B can be transmitted from adults with naturally acquired community influenza infection to healthy adult recipients under controlled inpatient exposure conditions, and to identify donor, recipient, viral, immunologic, behavioral, and environmental factors associated with transmission. This study differs from a traditional influenza CHIM because no challenge stock will be administered. Instead, naturally infected community donors will serve as the source of exposure. This approach is intended to better reflect naturally circulating influenza viruses and naturally infected donors while preserving the safety advantages of inpatient monitoring, defined exposure windows, controlled environmental measurements, and standardized sampling.

Waitlist Available
Has No Placebo

Emory University Hospital (EUH) (+1 Sites)

Nadine Rouphael, MD, MSc

Have you considered Tussicaps clinical trials?

We made a collection of clinical trials featuring Tussicaps, we think they might fit your search criteria.
Go to Trials
Image of SMS Clinical Research LLC in Garland, United States.

Tilrekimig for Severe Asthma

12 - 80
All Sexes
Garland, TX

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. The study is seeking participants who: * Have a history of severe asthma for at least 12 months * Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given shots of study medicine or a placebo at the study clinic. The study will compare the experiences of people receiving tilrekimig to those people who receive the placebo. This will help determine if tilrekimig is safe and effective.

Phase 3
Recruiting

SMS Clinical Research LLC (+6 Sites)

Pfizer CT.gov Call Center

Pfizer

Have you considered Tussicaps clinical trials?

We made a collection of clinical trials featuring Tussicaps, we think they might fit your search criteria.
Go to Trials